These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21438668)

  • 1. No effect of Implanon® on inflammatory cardiovascular parameters.
    Merki-Feld GS; Rosselli M; Imthurn B; Spanaus K
    Gynecol Endocrinol; 2011 Nov; 27(11):951-5. PubMed ID: 21438668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implanon use lowers plasma concentrations of high-molecular-weight adiponectin.
    Merki-Feld GS; Imthurn B; Rosselli M; Spanaus K
    Fertil Steril; 2011 Jan; 95(1):23-7. PubMed ID: 20576266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the progestagen-only contraceptive implant Implanon on cardiovascular risk factors.
    Merki-Feld GS; Imthurn B; Seifert B
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):355-60. PubMed ID: 17854390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the progestagen-only contraceptive implant Implanon on transforming growth factor beta1 and endothelin-1.
    Merki-Feld GS; Imthurn B; Seifert B
    Horm Metab Res; 2008 Oct; 40(10):692-6. PubMed ID: 18500679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
    Biswas A; Biswas S; Viegas OA
    Contraception; 2004 Nov; 70(5):379-82. PubMed ID: 15504376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion and removal of Implanon: practical considerations.
    Mascarenhas L
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():29-34. PubMed ID: 11246605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of etonogestrel implant on serum lipids, liver function tests and hemoglobin levels.
    Dilbaz B; Ozdegirmenci O; Caliskan E; Dilbaz S; Haberal A
    Contraception; 2010 Jun; 81(6):510-4. PubMed ID: 20472118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
    Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Implanon insertion and removal.
    Levine JP; Sinofsky FE; Christ MF;
    Contraception; 2008 Nov; 78(5):409-17. PubMed ID: 18929739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin.
    Dvoráková-Lorenzová A; Suchánek P; Havel PJ; Stávek P; Karasová L; Valenta Z; Tintĕra J; Poledne R
    Metabolism; 2006 Mar; 55(3):359-65. PubMed ID: 16483880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discontinuation rate and reasons for discontinuation of implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria.
    Ezegwui HU; Ikeako LC; Ishiekwene CI; Oguanua TC
    Niger J Med; 2011; 20(4):448-50. PubMed ID: 22288321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Office device to aid in Implanon insertion.
    Reiner IJ; Castracane VD
    Contraception; 2011 Nov; 84(5):445-6. PubMed ID: 22018118
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic effects of contraceptive implants in adolescents.
    Guazzelli CA; de Queiroz FT; Barbieri M; Barreiros FA; Torloni MR; Araujo FF
    Contraception; 2011 Oct; 84(4):409-12. PubMed ID: 21920197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia.
    Shakeri A; Tabibi H; Hedayati M
    Hemodial Int; 2010 Oct; 14(4):498-504. PubMed ID: 20812958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant.
    Bennink HJ
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():12-20. PubMed ID: 11246602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects.
    Belza A; Toubro S; Stender S; Astrup A
    Int J Obes (Lond); 2009 Apr; 33(4):456-64. PubMed ID: 19238154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.